Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Aug 3;188(3):497-503.
doi: 10.1084/jem.188.3.497.

Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11

Affiliations

Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11

D J Schust et al. J Exp Med. .

Abstract

US11 and US2 encode gene products expressed early in the replicative cycle of human cytomegalovirus (HCMV), which cause dislocation of human and murine major histocompatibility complex (MHC) class I molecules from the lumen of the endoplasmic reticulum to the cytosol, where the class I heavy chains are rapidly degraded. Human histocompatibility leukocyte antigens (HLA)-C and HLA-G are uniquely resistant to the effects of both US11 and US2 in a human trophoblast cell line as well as in porcine endothelial cells stably transfected with human class I genes. Dislocation and degradation of MHC class I heavy chains do not appear to involve cell type-specific factors, as US11 and US2 are fully active in this xenogeneic model. Importantly, trophoblasts HLA-G and HLA-C possess unique characteristics that allow their escape from HCMV-associated MHC class I degradation. Trophoblast class I molecules could serve not only to block recognition by natural killer cells, but also to guide virus-specific HLA-C- and possibly HLA-G-restricted cytotoxic T-lymphocytes to their targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HLA-G and HLA-Cw*0401 from JEG 3 trophoblast-derived cells are not degraded in the presence of the HCMV gene product US11. Approximately 107 JEG 3 cells were either infected with a vaccinia virus expressing the murine class I heavy chain, Kb (lacking its cytoplasmic tail, VVKb, MOI = 5), or doubly infected with VVKb (MOI = 5) and a vaccinia virus expressing the HCMV gene product US11 (VVUS11, MOI = 5). Cells were metabolically pulse labeled for 15 min with [35S]methionine and chased with unlabeled media for 0 and 30 min. Lysates of these cells were sequentially immunoprecipitated with an antibody against mouse heavy chain (RafHC), with W6/32, and with αUS11.
Figure 2
Figure 2
In vitro–translated HLA-A2 associates with cotranslated US2 and β2m; in vitro– translated trophoblast MHC class I heavy chains do not. (A) Human MHC class I heavy chains (HLA-A2, HLA-G, and HLA-C) were cotranslated in vitro with human β2m and US2. Radioactively labeled translation products were either separated directly by SDS-PAGE, or were immunoprecipitated with W6/32 before electrophoretic analysis. As indicated, components of the cotranslation are present at the anticipated position in the direct load samples. (B) US2 fails to be coprecipitated with HLA-G and β2m, despite optimization of the relative quantities of translated heavy chain, β2m, and US2. Increasing amounts of transcribed US2 were added to the cotranslation mixture of HLA-G, β2m, and US2 to allow relative quantities of class I heavy chain to US2 similar to those demonstrated for HLA-A2 in A. Lanes 1–4 represent separate translation mixtures in which the amounts of transcribed HLA-G and β2m template were constant but transcribed US2 template was present at a ratio of 2:1, 5:1, 10:1, and 20:1, respectively. W6/32 immunoprecipitation and electrophoresis were as described above.
Figure 2
Figure 2
In vitro–translated HLA-A2 associates with cotranslated US2 and β2m; in vitro– translated trophoblast MHC class I heavy chains do not. (A) Human MHC class I heavy chains (HLA-A2, HLA-G, and HLA-C) were cotranslated in vitro with human β2m and US2. Radioactively labeled translation products were either separated directly by SDS-PAGE, or were immunoprecipitated with W6/32 before electrophoretic analysis. As indicated, components of the cotranslation are present at the anticipated position in the direct load samples. (B) US2 fails to be coprecipitated with HLA-G and β2m, despite optimization of the relative quantities of translated heavy chain, β2m, and US2. Increasing amounts of transcribed US2 were added to the cotranslation mixture of HLA-G, β2m, and US2 to allow relative quantities of class I heavy chain to US2 similar to those demonstrated for HLA-A2 in A. Lanes 1–4 represent separate translation mixtures in which the amounts of transcribed HLA-G and β2m template were constant but transcribed US2 template was present at a ratio of 2:1, 5:1, 10:1, and 20:1, respectively. W6/32 immunoprecipitation and electrophoresis were as described above.
Figure 3
Figure 3
HLA-A2 is degraded in porcine endothelial cells in the presence of either US2 or US11. Approximately 107 2A2-A2/8.3, HLA-A2–expressing porcine endothelial cells were either infected with a vaccinia virus driving the expression of US2 (VVUS2, MOI = 5), with VVUS11 (MOI = 5), or left uninfected (Uninf). Cells were pretreated with the proteasome inhibitor, ZL3H, for 45 min, pulse labeled for 15 min with [35S]methionine, and then chased with unlabeled media for 0 and 30 min (all in the presence of ZL3H). Lysed cells were sequentially immunoprecipitated with a polyclonal antibody against class I heavy chain, RαHC, and with αUS11 and αUS2. 10 × 106 parental 2A2 cells were included as a specificity control for the RαHC antibody and were pretreated, pulse labeled, and lysed as above. These lysates were immunoprecipitated with RαHC only. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively).
Figure 3
Figure 3
HLA-A2 is degraded in porcine endothelial cells in the presence of either US2 or US11. Approximately 107 2A2-A2/8.3, HLA-A2–expressing porcine endothelial cells were either infected with a vaccinia virus driving the expression of US2 (VVUS2, MOI = 5), with VVUS11 (MOI = 5), or left uninfected (Uninf). Cells were pretreated with the proteasome inhibitor, ZL3H, for 45 min, pulse labeled for 15 min with [35S]methionine, and then chased with unlabeled media for 0 and 30 min (all in the presence of ZL3H). Lysed cells were sequentially immunoprecipitated with a polyclonal antibody against class I heavy chain, RαHC, and with αUS11 and αUS2. 10 × 106 parental 2A2 cells were included as a specificity control for the RαHC antibody and were pretreated, pulse labeled, and lysed as above. These lysates were immunoprecipitated with RαHC only. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively).
Figure 4
Figure 4
HLA-G stably expressed in porcine endothelial cells is resistant to class I heavy chain degradation associated with US2 and US11. Identical experiments to those described for Fig. 3 were performed using 2A2-HLA-G/1.2 cells, a porcine endothelial cell line stably transfected with HLA-G. For these experiments, primary RαHC immunoprecipitates were reimmunoprecipitated with RαHC before SDS-PAGE. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively). Uninf, Uninfected.
Figure 4
Figure 4
HLA-G stably expressed in porcine endothelial cells is resistant to class I heavy chain degradation associated with US2 and US11. Identical experiments to those described for Fig. 3 were performed using 2A2-HLA-G/1.2 cells, a porcine endothelial cell line stably transfected with HLA-G. For these experiments, primary RαHC immunoprecipitates were reimmunoprecipitated with RαHC before SDS-PAGE. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively). Uninf, Uninfected.
Figure 5
Figure 5
HLA-Cw3 stably expressed in porcine endothelial cells is resistant to class I heavy chain degradation associated with US2 and US11. Identical experiments to those described for Figs. 3 and 4 were performed using 2A2-HLA-Cw3/7 cells, a porcine endothelial cell line stably transfected with HLA-Cw3. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively). Uninf, Uninfected.
Figure 5
Figure 5
HLA-Cw3 stably expressed in porcine endothelial cells is resistant to class I heavy chain degradation associated with US2 and US11. Identical experiments to those described for Figs. 3 and 4 were performed using 2A2-HLA-Cw3/7 cells, a porcine endothelial cell line stably transfected with HLA-Cw3. (A) Immunoprecipitations with the polyclonal anti–human MHC class I heavy chain antibody, RαHC. (B) Immunoprecipitations with polyclonal antibodies raised against US2 and US11 (αUS2 and αUS11, respectively). Uninf, Uninfected.

Similar articles

Cited by

References

    1. Hammer A, Hutter H, Dohr G. HLA class I expression on the materno-fetal interface. Am J Reprod Immunol. 1997;38:150–157. - PubMed
    1. Hutter H, Hammer A, Blaschitz A, Hartmann M, Ebbesen P, Dohr G, Ziegler A, Uchanska-Ziegler B. Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res. 1996;286:439–447. - PubMed
    1. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol. 1996;156:2068–2076. - PubMed
    1. Sernee, M., H. Ploegh, and D. Schust. 1998. Why HLA-G and HLA-A cross-react: Epitope mapping of two common anti-MHC class I antibodies. Mol. Immunol. In press. - PubMed
    1. Yelavarthi K, Fishback J, Hunt J. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol. 1991;146:2847–2854. - PubMed

Publication types

MeSH terms